Incidence of Post-Dural Puncture Headache in Research Volunteers

Objective.— To determine the frequency and risk factors of post‐dural puncture headache (PDPH) in research volunteers. Background.— Despite increasing interest in measuring cerebrospinal fluid (CSF) biomarkers to investigate disease pathogenesis and diagnosis, previous case series have evaluated lum...

Full description

Saved in:
Bibliographic Details
Published inHeadache Vol. 51; no. 10; pp. 1503 - 1510
Main Authors de Almeida, Sérgio Monteiro, Shumaker, Stephanie D., LeBlanc, Shannon K., Delaney, Patrick, Marquie-Beck, Jennifer, Ueland, Susan, Alexander, Terry, Ellis, Ronald J.
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.11.2011
Wiley-Blackwell
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective.— To determine the frequency and risk factors of post‐dural puncture headache (PDPH) in research volunteers. Background.— Despite increasing interest in measuring cerebrospinal fluid (CSF) biomarkers to investigate disease pathogenesis and diagnosis, previous case series have evaluated lumbar puncture (LP) safety only in clinical care. PDPH is a common complication after LP. Methods.— We determined the frequency of PDPH in neurologically unselected HIV seropositive and seronegative adults volunteering for research, as well as the variables associated with the development of PDPH. Variables studied were body mass index (BMI), HIV serostatus, volume of CSF removed, number of previous LPs, use of pre‐medication, LP position, lumbar space, number of needle passes, whether or not aspiration was used, CSF white blood cell counts, CSF red blood cell counts, CD4 count, CD4 nadir, CSF HIV viral load, plasma HIV viral load, and race. Results.— Of 675 LPs performed over 1 year, headache developed in 38 (5.6%; 95% CI 4.2, 7.1). Most PDPH (92%) resolved spontaneously or with conservative medical management; 3 required epidural blood patch. Greater headache risk was associated with lower BMI (BMI ≤25 vs >25) (OR 3.3; CI 95% 1.5, 7.0; P = .001) and less prior LP experience (previous LPs ≤2 vs >2) (OR 2.1; CI 95% 1.1, 4.1; P = .03). PDPH was not significantly (P > .05) related to HIV serostatus, CSF volume, or gender. Conclusion.— In this study, where tolerance to risk was low because LPs were done for research rather than clinical purposes and healthy controls were included, adverse effects were mild and self‐limited.
Bibliography:ark:/67375/WNG-562CFCJ9-Q
ArticleID:HEAD1959
istex:E1FF981168F8D763FD26A08269B0CCAAC3DA928D
None
Conflict of Interest
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0017-8748
1526-4610
DOI:10.1111/j.1526-4610.2011.01959.x